Skip to main content
Sisram Medical Ltd logo

Sisram Medical Ltd — Investor Relations & Filings

Ticker · 1696 ISIN · IL0011418113 HKEX Manufacturing
Open in API
Filings indexed 1,569 across all filing types
Latest filing 2026-06-02 Regulatory Filings
Country HK Hong Kong
Listing HKEX 1696

About Sisram Medical Ltd

http://www.sisram-medical.com

Sisram Medical Ltd. is a global consumer wellness group specializing in medical aesthetics and minimally invasive solutions. Leveraging over two decades of expertise, the company is a leader in Energy-Based Devices (EBD), harnessing natural energy sources for both aesthetic and medical clinical indications. Sisram operates through a synergistic ecosystem of brands, providing medical-grade quality solutions to professional customers and consumers worldwide. Key segments include Alma, a provider of energy-based solutions for surgical and medical aesthetics markets; LMNT, a personal care brand for home use; Copulla, which offers end-to-end digital dentistry services; and a dedicated injectables portfolio. The company's extensive product range covers treatments such as hair removal, skin rejuvenation, body contouring, and dermal fillers.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2026
Regulatory Filings Classification · 75% confidence The document is a standard monthly return (Form FF301) filed with the Hong Kong Exchange detailing movements in authorised/issued share capital and public float confirmation under Chapter 19B Listing Rules. It is a compliance/regulatory filing rather than a financial report, management discussion, capital raising announcement or proxy statement. Therefore it falls into the general “Regulatory Filings” category.
2026-06-02 English
CONTINUING CONNECTED TRANSACTION RELATING TO THE NEW SUPPLY FRAMEWORK AGREEMENT
Regulatory Filings Classification · 87% confidence The document is a Hong Kong Stock Exchange announcement regarding a continuing connected transaction (a new supply framework agreement) and the associated EGM and circular, rather than a financial report, earnings release, or management discussion. It is a regulatory announcement required under the Listing Rules, with no substantive financial statements or investor presentation content. Thus it best fits under the fallback category “Regulatory Filings (RNS).”
2026-05-22 English
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING ON WEDNESDAY, 24 JUNE 2026
AGM Information Classification · 95% confidence The document is a Form of Proxy for the Annual General Meeting (AGM) of Sisram Medical Ltd scheduled for 24 June 2026. It includes instructions for shareholders to appoint proxies and vote on various resolutions, including receiving the audited financial statements, re-electing directors, appointing auditors, and granting mandates related to share buybacks and issuance. The content is typical of proxy materials distributed ahead of an AGM to facilitate shareholder voting. It is not the AGM presentation itself, nor is it the actual voting results announcement. It is also not a full annual report or financial statement. Therefore, the document fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the AGM, including proxy forms.
2026-05-19 English
NOTICE OF ANNUAL GENERAL MEETING
AGM Information Classification · 100% confidence The document is a notice of the Annual General Meeting (AGM) for Sisram Medical Ltd, scheduled for June 24, 2026. It includes details about the meeting agenda such as receiving the audited financial statements, re-election of directors, re-appointment of auditors, and mandates for share buy-back and issuance. The document is a formal notice inviting shareholders to attend and vote at the AGM, not the actual annual report or financial statements themselves. It is a typical AGM notice document, which fits the category of AGM Information (AGM-R). The document length is over 12,000 characters, indicating it is a full notice rather than a brief announcement. Therefore, the correct classification is AGM Information (AGM-R).
2026-05-19 English
PROPOSED RE-ELECTION OF DIRECTORS AND PROPOSED RE-APPOINTMENT OF AUDITOR AND PROPOSED GRANTING OF GENERAL MANDATES TO BUY BACK SHARES AND TO ISSUE SHARES AND PROPOSED RE-APPOINTMENT OF EXTERNAL DIRECT
AGM Information Classification · 100% confidence The document is a circular dated 20 May 2026 from Sisram Medical Ltd regarding the upcoming Annual General Meeting (AGM) scheduled for 24 June 2026. It includes detailed information about proposed re-election of directors, re-appointment of auditor, granting of general mandates to buy back and issue shares, and re-appointment of external directors. It also contains the notice of the AGM and proxy arrangements. The content is typical of materials sent to shareholders ahead of an AGM to inform them of the agenda and resolutions to be voted on. The document is lengthy (15,000 characters) and contains substantive information, not just a brief announcement or notice. This fits the definition of AGM Information (AGM-R), which includes presentations and materials shared during the AGM. It is not an Annual Report or Audit Report, nor is it a voting results announcement or proxy solicitation statement. Therefore, the correct classification is AGM Information (AGM-R).
2026-05-19 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2026
Regulatory Filings Classification · 95% confidence The document is a monthly return filed with the Hong Kong Exchanges and Clearing Limited (HKEX) regarding movements in securities for Sisram Medical Ltd. It details movements in authorised share capital, issued shares, treasury shares, and public float sufficiency confirmation. The document is a regulatory submission related to share capital and shareholding disclosures, not a financial report, earnings release, or management discussion. It is not an announcement of a report publication but a regulatory filing itself. The content aligns with regulatory compliance filings about share capital and public float, which fits best under Regulatory Filings (RNS).
2026-05-06 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.